portfolio as of Q2 2026, filed Aug 14, 2026
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
15 of 41 holdings are Undervalued or On Sale by our valuation (38% of the money).
Valued by PaybackPrice; holdings from SEC 13F filings as of Jun 30, 2026. 13 not valued.
Hillman Capital Management's portfolio holds 54 stocks worth $138.2M at the end of Q2 2026. The largest positions are CVS, BIIB, DD, WBD and BAX.
In Q2 2026, Hillman Capital Management opened 3 new positions (DD, VEEV and ACN) and added to CAG, CSGP, INTU, IVV, CRM, TMO and MDT.
In Q2 2026, Hillman Capital Management sold out of 6D81.DE, GE, IGOV, BWX and SPLG and trimmed AKAM, GOOGL, BIIB, BMY, CVS, KMX, STZ, IFF, IWR, ORCL, TROW, TSM, USB-PM, UNH, VZ and WST.
ZBH, KHC, PFE, CPB, ADBE, NKE, CMCSA, CAG, UPS, CRM, EFX, ORCL, TROW, CLX and INTU are Undervalued or On Sale by our valuation.
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
From SEC Form 13F-HR — up to 45 days old at time of filing. Not a recommendation to buy or sell. Analyze any of these free →